PROCTER & GAMBLE Co (PG) Insider Transactions
Explore official ownership filings, with every record linked to its source.
PG · PROCTER & GAMBLE Co
How to read this data ↗Recent reported activity
Purchases and sales count original non-derivative P and S rows. Awards, gifts, exercises, derivatives and amendments are shown separately and are not described as market purchases.
| Transaction / filed | Reporting owner(s) | Code / security | Quantity | Price as filed | Ownership | Source |
|---|---|---|---|---|---|---|
| 2026-10-13Filed 2026-10-14 | Biggs M. BrettDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 Total includes grant of dividend equivalents in the form of Restricted Stock Units. References: F1, F2 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000217 |
| 2026-10-13Filed 2026-10-14 | Bonini SheilaDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 Total includes grant of dividend equivalents in the form of Restricted Stock Units. References: F1, F2 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000218 |
| 2026-10-13Filed 2026-10-14 | Chang AmyDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 Total includes grant of dividend equivalents in the form of Restricted Stock Units. References: F1, F2 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000219 |
| 2026-10-13Filed 2026-10-14 | JIMENEZ JOSEPHDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000220 |
| 2026-10-13Filed 2026-10-14 | Kempczinski Christopher JDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000221 |
| 2026-10-13Filed 2026-10-14 | McCarthy Christine MDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000222 |
| 2026-10-13Filed 2026-10-14 | McEvoy AshleyDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Common Stock awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000223 |
| 2026-10-13Filed 2026-10-14 | Portman Robert JonesDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000224 |
| 2026-10-13Filed 2026-10-14 | Subramaniam RajeshDirectorFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. F2 Total includes grant of dividend equivalents in the form of Restricted Stock Units. References: F1, F2 | A Award / grantCommon Stock · Non-derivative | 1,438A | 0 | Direct | Form 4 ↗0000080424-26-000225 |
| 2026-10-05Filed 2026-10-06 | Schulten AndreOfficer · Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover tax obligations upon settlement of Restricted Stock Unit Award. F2 Reflects adjustment to PST through September 30, 2026. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 3,914D | 145.34 | Direct | Form 4 ↗0000080424-26-000200 |
| 2026-10-05Filed 2026-10-06 | Gama PaulOfficer · CEO- Health CareFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover tax obligation upon settlement of Restricted Stock Unit award. F2 Reflects adjustment to PST through September 30, 2026. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 2,225D | 145.34 | Direct | Form 4 ↗0000080424-26-000199 |
| 2026-10-05Filed 2026-10-06 | Whaley Susan StreetOfficer · Chief Legal Officer & SecyFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 Reflects adjustment to PST through September 30, 2026. References: F1 | S Sale (market/private)Common Stock · Non-derivative | 2,369D | 145.34 | Direct | Form 4 ↗0000080424-26-000198 |
| 2026-10-01Filed 2026-10-05 | Whaley Susan StreetOfficer · Chief Legal Officer & SecyFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: | A Award / grantStock Option (Right to Buy) · Derivative | 24,330A | 0 | Direct | Form 4 ↗0000080424-26-000197 |
| 2026-10-01Filed 2026-10-05 | Whaley Susan StreetOfficer · Chief Legal Officer & SecyFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 6,110A | 0 | Direct | Form 4 ↗0000080424-26-000197 |
| 2026-10-01Filed 2026-10-05 | Schulten AndreOfficer · Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: | A Award / grantStock Option (Right to Buy) · Derivative | 78,324A | 0 | Direct | Form 4 ↗0000080424-26-000196 |
| 2026-10-01Filed 2026-10-05 | Schulten AndreOfficer · Chief Financial OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 6,557A | 0 | Direct | Form 4 ↗0000080424-26-000196 |
| 2026-10-01Filed 2026-10-05 | Gama PaulOfficer · CEO- Health CareFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 12,517A | 0 | Direct | Form 4 ↗0000080424-26-000195 |
| 2026-10-01Filed 2026-10-05 | Jejurikar ShaileshDirector · Officer · Chairman, President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: | A Award / grantStock Option (Right to Buy) · Derivative | 191,909A | 0 | Direct | Form 4 ↗0000080424-26-000194 |
| 2026-10-01Filed 2026-10-05 | Jejurikar ShaileshDirector · Officer · Chairman, President and CEOFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 16,065A | 0 | Direct | Form 4 ↗0000080424-26-000194 |
| 2026-10-01Filed 2026-10-05 | Aguilar Moses Victor JavierOfficer · Chf Rsch, Dev & Innov OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: | A Award / grantStock Option (Right to Buy) · Derivative | 22,822A | 0 | Direct | Form 4 ↗0000080424-26-000193 |
| 2026-10-01Filed 2026-10-05 | Aguilar Moses Victor JavierOfficer · Chf Rsch, Dev & Innov OfficerFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 5,732A | 0 | Direct | Form 4 ↗0000080424-26-000193 |
| 2026-10-01Filed 2026-10-05 | Santos de Azevedo Juliana MonteiroOfficer · CEO - GroomingFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: | A Award / grantStock Option (Right to Buy) · Derivative | 37,382A | 0 | Direct | Form 4 ↗0000080424-26-000192 |
| 2026-10-01Filed 2026-10-05 | Santos de Azevedo Juliana MonteiroOfficer · CEO - GroomingFiling contextReported filing row; may be amended. Do not sum filings blindly. F1 Restricted Stock Units awarded pursuant to The Procter & Gamble 2025 Stock and Incentive Compensation Plan. References: F1 | A Award / grantCommon Stock · Non-derivative | 3,130A | 0 | Direct | Form 4 ↗0000080424-26-000192 |
| 2026-10-01Filed 2026-10-05 | Bharucha Freddy P.Officer · CEO - BeautyFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | A Award / grantStock Option (Right to Buy) · Derivative | 3,126A | 0 | IndirectBy Spouse | Form 4 ↗0000080424-26-000191 |
| 2026-10-01Filed 2026-10-05 | Bharucha Freddy P.Officer · CEO - BeautyFiling contextReported filing row; may be amended. Do not sum filings blindly. References: | A Award / grantStock Option (Right to Buy) · Derivative | 49,843A | 0 | Direct | Form 4 ↗0000080424-26-000191 |
Imported instruments only. Joint owners do not multiply transactions. Amendments are separate filing rows, not additional trades. No aggregate trade totals are implied.